Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Pulmonary Circulation|December 22, 2025
Real-World Dosing and Persistence of Oral Treprostinil Initiation Strategies in Patients With Pulmonary Arterial HypertensionDaniel J Lachant, Ali Ataya, H James Ford, et al.
Clinical Pharmacokinetics|May 17, 2017
Population Pharmacokinetic and Pharmacodynamic Modeling of Etelcalcetide in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving HemodialysisPing Chen, Adimoolam Narayanan, Benjamin Wu, et al.
Pulmonary Circulation|June 26, 2026
Patient Perspectives on Palliative Care in Pulmonary Arterial Hypertension in the United StatesKarim El-Kersh, Rebecca Crawford, Hilary DuBrock, et al.
Experimental Cell Research|September 8, 2004
BMP-2 exerts differential effects on differentiation of rabbit bone marrow stromal cells grown in two-dimensional and three-dimensional systems and is required for in vitro bone formation in a PLGA scaffoldWeibiao Huang, Brian Carlsen, Isabella Wulur, et al.
Biotechnology and Bioengineering|September 16, 2024
Electrobiofabrication of antibody sensor interfaces within a 3D printed device yield rapid and robust electrochemical measurements of titer and glycan structureChen-Yu Chen, Dana Motabar, Fauziah Rahma Zakaria, et al.
Liver Cancer|November 1, 2021
Atezolizumab and Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Pharmacokinetic and Safety Assessments Based on Hepatic Impairment Status and Geographic RegionColby S Shemesh, Phyllis Chan, Hui Shao, et al.
Frontiers in Medicine|January 3, 2022
Randomized Controlled Trial Comparing 1-Year Outcomes of Low-Energy Femtosecond Laser-Assisted Cataract Surgery versus Conventional PhacoemulsificationYu-Chi Liu, Melina Setiawan, Jia Ying Chin, et al.
Tissue Engineering|February 27, 2007
MicroCT evaluation of three-dimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defectsCatherine M Cowan, Tara Aghaloo, Yu-Fen Chou, et al.
BMC Health Services Research|May 31, 2024
Healthcare resource utilization and costs in patients with a newly confirmed diagnosis of lupus nephritis in the United States over a 5-year follow-up periodChristopher F Bell, Benjamin Wu, Shirley P Huang, et al.
The AAPS Journal|April 28, 2022
Tumor Growth Inhibition-Overall Survival (TGI-OS) Model for Subgroup Analysis Based on Post-Randomization Factors: Application for Anti-drug Antibody (ADA) Subgroup Analysis of Atezolizumab in the IMpower150 StudyKenta Yoshida, Phyllis Chan, Mathilde Marchand, et al.
Pageof 15